These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Serum lipids levels, lipoprotein phenotypes and analysis of lipoprotein in Italian population group (author's transl)]. Avogaro P, Cazzolato G, Capri C, Pais M, Trabuio GF. G Ital Cardiol; 1974; 4(2):237-48. PubMed ID: 4365662 [No Abstract] [Full Text] [Related]
28. A comparative study of a new drug MK 185 with clofibrate in the treatment of hyperlipidaemias. Jepson EM, Small E, Grayson MF, Bance G, Billimoria JD. Atherosclerosis; 1972; 16(1):9-14. PubMed ID: 4341723 [No Abstract] [Full Text] [Related]
29. Familial lipoatrophic diabetes with dominant transmission. A new syndrome. Dunnigan MG, Cochrane MA, Kelly A, Scott JW. Q J Med; 1974 Jan; 43(169):33-48. PubMed ID: 4362786 [No Abstract] [Full Text] [Related]
30. [Clofibrate action on the lipoprotein composition in primary type IV and type V hyperlipoproteinemia]. Weisweiler P, Schwandt P. Verh Dtsch Ges Inn Med; 1974 Jan; 83():398-401. PubMed ID: 206058 [No Abstract] [Full Text] [Related]
31. Bile acid metabolism in hyperlipoproteinaemia. Hellström K, Einarsson K. Clin Gastroenterol; 1977 Jan; 6(1):103-28. PubMed ID: 196796 [No Abstract] [Full Text] [Related]
37. [Value of ultracentrifugation in the study of hyperlipoproteinemias]. Loeper J, Rouffy J, Jeny R. Ann Med Interne (Paris); 1975 Mar; 126(3):217-22. PubMed ID: 164813 [No Abstract] [Full Text] [Related]
38. The effects of carbohydrate, fat and total energy adjustment of Fredrickson's type IIb hyperlipoproteinaemia. Watermeyer GS, Manning E. S Afr Med J; 1977 Jan 15; 51(3):71-3. PubMed ID: 189446 [Abstract] [Full Text] [Related]
39. [Therapy of hyperlipemia and hyperuricemia with a combination of clofibrate and an extractive mucopolysaccharide complex]. Loizzi P, Terlizzi N. Reumatismo; 1975 Jan 15; 27(1):157-62. PubMed ID: 184507 [No Abstract] [Full Text] [Related]